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Background: The development of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)
technique for species identification among patients presenting leishmaniasis allowed to better determine the main
circulating species in French Guiana.
Methods: A descriptive study of the Leishmania species was identified, and their spatiotemporal distribution was
conducted using patient records between 2006 and 2013, with 1017 new cases of leishmaniasis diagnosed.
Identification was realized by PCR-RFLP on 745 cases.
Results: The average proportions for different species were 86.2% for Leishmania (Vianna) guyanensis; 9.7% for
Leishmania (Vianna) braziliensis; 2.8% for Leishmania (Leishmania) amazonensis; and 1.3% for Leishmania (Vianna)
lainsoni, and no case of Leishmania (Vianna) naiffi was identified. Over this period, the proportion of cases due to L.
(V.) braziliensis seemed to increase from 8.9% in 2006 to 13.0% in 2013 notably near the gold mining zones.
Conclusions: The use of molecular tools has transformed the view of the local epidemiology of cutaneous
leishmaniasis in French Guiana.
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Considered like a “neglected tropical disease” by the
World Health Organization [1], cutaneous leishmaniasis
is a well-known parasitosis firmly established in South
America [2–4]. In French Guiana, leishmaniasis was
described for the first time in 1954 [5]. The annual inci-
dence rate was estimated between 15 and 20 new cases
per 10,000 inhabitants between 1979 and 2012 [6–8].
Five human Leishmania species have been described
in French Guiana: Leishmania (Viannia) guyanensis,
Leishmania (Viannia) braziliensis, Leishmania (Leish-
mania) amazonensis, Leishmania (Viannia) lainsoni,
and Leishmania (Viannia) naiffi [9, 10]. These species
all have a cutaneous tropism. The previous descriptions* Correspondence: marine.ginouves@univ-guyane.fr
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(http://creativecommons.org/publicdomain/zeof the local epidemiology in French Guiana suggested
that L. (V.) guyanensis is by far the predominant species
[11] most frequently responsible for localized cutaneous
presentations, but it may at times lead to diffuse pre-
sentations [12]. Leishmania (Vianna) braziliensis is a
more virulent species that is potentially responsible for
mucous involvement (nose, mouth, and throat). In
French Guiana, there was no case caused by L. (V.) bra-
ziliensis described before 1986, and only nine cases
have been diagnosed between 1987 and 1996 [13].
However, when these studies were undertaken, cultures
were rarely performed and only when the patient’s le-
sion did not heal or show some clinical particularities.
The development in 2005 of a polymerase chain
reaction-restriction fragment length polymorphism (PCR-
RFLP) technique, by the parasitology-mycology university
laboratory in Cayenne [14], allowed a more systematic spe-
cies identification among patients presenting leishmaniasis
lesions.
In this context, the objective of this paper is to up-
date the epidemiological situation of leishmaniasis inle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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This study aims to describe the spatiotemporal distribu-
tion of human cases of cutaneous leishamaniasis from
the cohort of the parasitology laboratory of Cayenne
General Hospital (LHUPM) in French Guiana between 1
January 2006 and 31 December 2013. The identification
of Leishmania species corresponded to the surveillance
and alert mission of the National Reference Center
(CNR) of Leishmania for which the LHUPM constitutes
a local relay.
Type of study
The study was observational, retrospective, and
monocentric.
Study population
The study population was the patients in consultation
for a suspicion of leishmaniasis at the LHUPM and in
the health centers of the interior (administratively at-
tached to Cayenne General Hospital) between 1 January
2006 and 31 December 2013. New cases were defined as
cases without a history of leishmianasis in the past
12 months. Diagnosis was confirmed by the presence of
Leishmania parasites on microscopic examination of
May-Grünwald Giemsa-colored skin smears, and/or by a
positive culture on RPMI culture medium, and/or by the
detection of Leishmania DNA by PCR. During this
period, 1017 cases were detected and species identifica-
tion has been possible on 745 cases. This difference is
explained by the fact that for some patients, we only had
a stained slide, or in others, the PCR-RFLP did not allow
identification (insufficient Leishmania DNA quantity).
Study variables
The study variables were collected from standardized med-
ical forms which are part of medical records both at the
dermatology and the parasitology departments of Cayenne
General Hospital. These variables were the following:
consultation date, contamination location, profession, geo-
graphic origin, age, sex, and species of Leishmania identi-
fied. Presumptive contamination site was declared by the
patient during the consultation. For cases diagnosed in
health centers, the location was the township of the health
center, unless specified otherwise.
Leishmania identification
The species identification was performed by the Univer-
sity laboratory of Cayenne using a PCR-RFLP technique
in collaboration with the LHUPM [14]. Briefly, DNAwas extracted using DNeasy Tissue and Blood Kit
(Qiagen, Hilden, Germany), according to the manu-
facturer’s instructions. Then, the extracted DNA was
amplified with RPOF2 (5′-AGAACATGGGCGGCC-
3′) and RPOR2 (5′CGAGGGTCACGTTCTTG-3′)
primers (Eurogentec) which target a 615-bp region of
the RNA polymerase II gene. The PCR product was
digested with TspRI or HgaI (New England Biolabs).
The entire reaction mixture was then analyzed by electro-
phoresis in a 2% agarose gel containing ethidium bromide.
The resulting profile was species-specific. This identifica-
tion was performed from the culture of the biopsies taken
during consultations at dermatology department. If the
parasite has grown, the PCR-RFLP was performed on the
culture. If there was not growth, the PCR-RFLP was per-
formed on the biopsy.
Analysis
First, the analysis concerned the whole study population
in order to conduct a quality control of the data using
coherence tests and eventual queries to go back to the
patient records to clean the data. After this, comparisons
between proportions were performed using the chi-
square test and the linear chi-square test for trend in
order to identify any temporal trends. Data were ana-
lyzed with STATA 12 (College Station, Texas).
The analysis described the appropriate position and
dispersion measures for quantitative variables (mean and
standard deviation for Gaussian variables, median and
interquartile range (IQR) for non-Gaussian variables).
For qualitative variables, frequencies and proportions
were reported. The calculation of the annual incidence
was performed between 2006 and 2013 from the data of
dermatology and the parasitology departments. Cases
were reported to the total population of French Guiana
using the annual data from the National Institute for
Statistics and Economic Evaluation’s (INSEE) censuses
and projections.
Ethics statement
The study was retrospective. All patients were informed
(leaflets, posters in several local languages) that data and
analysis results may be used in research, and scientific
publications, and that they had a right to refuse.
Results
Between 1 January 2006 and 31 December 2013, 1017
new cases of leishmaniasis were diagnosed for an aver-
age of 127 cases per year, with interannual variations
between 96 and 160 cases per year. The annual inci-
dence oscillated between 4.6 and 7.0 cases per 10,000
inhabitants with an average of 5.6 cases/year (Fig. 1).
The median age of patients was 35 years ranging from 3
to 87 years of age (IQR = 28–45), and the sex ratio was
Fig. 1 Total number of leishmaniasis cases in French Guiana (2006–2013). The total number of cases (n = 1017) was in relation to the number of
inhabitants. The incidence rate was calculated per 10,000 inhabitants and per year
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tion was known in 525 cases (51.6%). The median date
of infection was 1 month before the consultation, ran-
ging from 0.25 to 360 months (IQR = 1–2). The number
of lesions was known in 568 cases (55.9%). The median
number was one lesion ranging from one to over 200
lesions (IQR = 1–2).
Among infected patients, 39.6% had an outdoor pro-
fessional occupation (29.9% of gold miners, 22.8% of
military, 14.1% of farmers, 11.4% of bricklayers, 9.2% ofFig. 2 Identification of leishmania species by PCR-RFLP method on 745 samworkers in the lumber industry); 43% had various urban
or peri-urban professions; 15.3% were not employed;
and 2.1% were pensioners. For 54.3% of patients, profes-
sion data was missing.
Concerning molecular diagnosis, 745 (73.3%) Leishmania
species identifications were performed. The difference is ex-
plained by the fact that sometimes we receive only MGG-
colored skin smears and no biopsy, but also as PCR-RFLP
on biopsy is trickier (quantity of Leishmania DNA too low).
Figure 2 illustrates the evolution of the proportion of casesples assessed between 2006 and 2013
Table 1 Identification of Leishmania strain in French Guiana between 2006–2013.
Year L. (V.) guyanensis L. (V.) braziliensis L. (L.) amazonensis L. (V.) lainsoni
N (%) N (%) N (%) N (%)
2006 (n = 45) 38 (84.4) 4 (8.9) 1 (2.2) 2 (4.4)
2007 (n = 82) 71 (86.6) 6 (7.3) 4 (4.9) 1 (1.2)
2008 (n = 80) 65 (81.3) 8 (10.0) 5 (6.3) 2 (2.5)
2009 (n = 93) 82 (88.2) 10 (10.8) 1 (1.1) 0 (0)
2010 (n = 144) 136 (94.4) 4 (2.8) 2 (1.4) 2 (1.4)
2011 (n = 96) 82 (85.4) 13 (13.5) 0 (0) 1 (1.0)
2012 (n = 113) 91 (80.5) 15 (13.3) 6 (5.3) 1 (0.9)
2013 (n = 92) 77 (83.7) 12 (13.0) 2 (2.2) 1 (1.1)
Total (n = 745) 642 (86.2) 72 (9.7) 21 (2.8) 10 (1.3)
For each year, the number of cases per species is given in absolute value (N) and percentage (%)
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guyanensis; 9.7% for L. (V.) braziliensis; 2.8% for L. (L.)
amazonensis; 1.3% for L. (V.) lainsoni; no case of L. (V.)
naiffi leishmaniasis was identified, but the proportion of
cases due to L. (V.) braziliensis increased from 8.9% in 2006
to 13.0% in 2013 (Table 1). Forty strains were sent to the
National Reference Center for Leishmania in Montpellier
(France) to confirm our diagnosis by multilocus enzyme
electrophoresis (MLEE) and/or by sequencing of RNA
polymerase II gene. Although L. (V.) panamensis, L. (L.)
colombiensis, and L. (L.) venezuelensis are endemic in some
countries in South America [16–18], these strains are not
found in French Guiana. However, since 2007, the propor-
tion of L. (V.) braziliensis has significantly increased (7.3 vs
13.3%, P = 0.005). The decrease observed in 2010 may have
been related to small numbers which increase the risk ofFig. 3 Average number of leishmaniasis cases in relation to average rainfalextreme values. The linear trend however failed to reach
statistical significance (P = 0.07).
The number of monthly cases diagnosed averaged over
the 8 years of the study showed a seasonal pattern with
a peak in January (23.3 cases) and a minimum in August
(1.4 cases) (Fig. 3).
The geographical distribution of 689 cases (67.7%) on
the known presumptive contamination site showed that
15.4% was concentrated in the townships of Maripasoula,
9.3% in Cacao, 7.7% in Regina, 6.8% in Saül, and 5.8% in
Grand Santi. On their 689 cases with a known presump-
tive contamination sites, species identification was pos-
sible in 561 cases. These sites were grouped into four
major areas (Fig. 4). The proportion of cases due to L. (V.)
braziliensis was higher in areas where gold mines were
located.l per month (2006–2013)
Fig. 4 Distribution of Leishmania species in four major areas
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L. (V.) guyanensis and three cases were due to L. (V.)
braziliensis. The frequency of mucosal forms due to L.
(V.) guyanensis was 0.9% and 4.2% for L. (V.) braziliensis.Discussion
Data from the 1980s suggested that L. (V.) braziliensis
did not circulate in French Guiana [19, 20]. The present
results showed that this is not the case today. Moreover,
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braziliensis globally seemed to increase linearly. The in-
crease of the cases due to this species could be linked to
the generalization of the species diagnosis that followed
from the local development of an identification
technique.
Indeed, before 2006, because of the difficulties of the
transatlantic transport of samples and the delays of the
isoenzymes technique, the search for the causative
species was mostly motivated by an unusual presentation
or an unfavorable evolution. It is thus probable that
cases of L. (V.) braziliensis leishmaniasis with a simple
common cutaneous uncomplicated presentation and
evolution were not identified. This hypothesis underlines
the interest of the exploitation of older biological collec-
tions, which could be suitable for species diagnosis by
PCR-RFLP. Another hypothesis for the apparent increase
of the proportion on L. (V.) braziliensis would be signs
of an emerging problem. This hypothesis was reinforced
by the apparent preponderance of cases near gold
mining sites.
The incidence calculated in the present study (5.6
cases/10,000 inhabitants/year) was four to five times
lower than the values reported in the literature [6, 7].
This difference is explained by the fact that the number
of cases of leishmaniasis remains stable while the popu-
lation is growing rapidly (113,351 in 1990 to 250,109 in
2013). The information collected allowed us to establish
a reliable indicator that shows a lower incidence during
the 1990s, but a relatively stable incidence with regular
seasonal variations, which still remains to be fully ex-
plained. The annual repartition of leishmaniasis diagno-
sis always follows a seasonal pattern as described
elsewhere [21, 22], which underlines the probable influ-
ence of climate on the transmission of the parasite. The
peak intensity of cases observed in 2010 may have been
influenced by the El Niño phenomenon in 2009–2010
[23]. Studies have shown that this phenomenon has an
impact on the increase of cases of leishmaniasis in South
America [24–27]. Correlations between climatic vari-
ables, vector populations, and human contaminations
have previously been described in neighboring countries
[27–29]. However, local studies could be useful to
complete the data with entomological studies and im-
prove the understanding of cycles of leishmaniasis in
French Guiana. It is not clear whether geographical dis-
tribution of the different Leishmania species is linked to
different human populations or different vector popula-
tions with different competencies for different parasites.
Conclusions
The molecular study using PCR-RFLP confirms the pres-
ence of L. (V.) braziliensis in French Guiana [14] with a
high proportion of cases than previously thought 10%rather than absent. The use of PCR-RFLP allows rapid
identification of Leishmania strains. Without treatment,
the risk for patients infected with L. (V.) braziliensis is to
develop, in some cases, the mucocutaneous form of the
disease. This precose identification allows a rapid man-
agement of the patients, which limits the appearance of
the cutaneomucous forms. Furthermore, species identifi-
cation will be further monitored as it is not clear that
the proportion of L. (V.) braziliensis increases signifi-
cantly in the context of intense gold mining or whether
we are now seeing its real impact due to the recent
introduction of the PCR-RFLP technique.
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